TrialTherapeutics and clinical risk management2026

Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series.

Huijing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.